PTH-induced cardiomyocyte hypertrophy may be an indirect effect of FGF-23 once high levels of FGF-23 have also been bonded to cardiac hypertrophy and mortality in CKD patients (Duque et al., 2020). Here, FGF23 is linked to cardiac hypertrophy.